The moderated pathway reflects the extent to which minoritized group status affects the association between CRP and incident dementia, which is greater than expected for individuals minoritized and racialized as non-Hispanic Black and/or Hispanic had these individuals been racialized and treated as non-Hispanic White. The gene discussed is CRP; the disease is dementia.